Elaine Ullian - Vertex Pharmaceuticals Co-Lead Independent Director

VRTX -- USA Stock  

Quarterly Earning Report: October 23, 2019  

  Director
Ms. Elaine S. Ullian is CoLead Independent Director of Vertex Pharmaceuticals Incorporated. Ms. Ullian was a member of our Board of Directors since 1997. Ms. Ullian served as President and Chief Executive Officer of Boston Medical Center, a private, notforprofit, 626bed, academic medical center with a communitybased focus, from 1996 through January 2010. From 1994 to 1996, she served as President and Chief Executive Officer of Boston University Medical Center Hospital. From 1987 to 1994, Ms. Ullian served as President and Chief Executive Officer of Faulkner Hospital. She also serves as a director of Thermo Fisher Scientific Inc. and Hologic, Inc
Age: 69  Director Since 2011      
617 341-6100  www.vrtx.com
Ullian holds a B.A. in political science from Tufts University and an M.P.H. from the University of Michigan.

Elaine Ullian Latest Insider Activity

Management Efficiency

The company has return on total asset (ROA) of 9.99 % which means that it generated profit of $9.99 on every $100 spent on asset. This is normal as compared to the sector avarege. Similarly, it shows return on stockholders equity (ROE) of 56.25 % meaning that it created $56.25 on every $100 dollars invested by stockholders.
The company currently holds 656.95 M in liabilities with Debt to Equity (D/E) ratio of 12.9 indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Vertex Pharmaceuticals has Current Ratio of 3.67 suggesting that it is liquid enough and is able to pay its financial obligations when they are due.

Similar Executives

Showing few of many executives

DIRECTOR Since

Shikha SharmaDr Reddys Laboratories Ltd
2019
Frank DAmelioZoetis
2016
Theodore SamuelsPerrigo Company Plc
2017
Omkar GoswamiDr Reddys Laboratories Ltd
2000
Christine PoonRegeneron Pharmaceuticals
2010
Louise ParentZoetis
2013
Arthur RyanRegeneron Pharmaceuticals
2003
Ellen HoffingPerrigo Company Plc
2008
George SingRegeneron Pharmaceuticals
1988
Charles BakerRegeneron Pharmaceuticals
N/A
Bonnie BasslerRegeneron Pharmaceuticals
2016
William DoyleZoetis
2015
Jacqualyn FousePerrigo Company Plc
2012
Paul BisaroZoetis
2015
Jeffrey KindlerPerrigo Company Plc
2017
Geoffery MerszeiOrigin Agritech Limited
2016
Gary CohenPerrigo Company Plc
2009
Shlomo YanaiPerrigo Company Plc
N/A
Larry CordellOrigin Agritech Limited
2012
Anupam PuriDr Reddys Laboratories Ltd
2002
James KangOrigin Agritech Limited
2010

Entity Summary

Vertex Pharmaceuticals Incorporated engages in developing and commercializing therapies for treating cystic fibrosis. The company was founded in 1989 and is headquartered in Boston, Massachusetts. Vertex Pharmaceuticals operates under Biotechnology classification in USA and is traded on BATS Exchange. It employs 2500 people.Vertex Pharmaceuticals Incorpor (VRTX) is traded on BATS Exchange in USA and employs 2,500 people.

Vertex Pharmaceuticals Leadership Team

William Young, Independent Director
Reshma Kewalramani, Executive Vice President - Global Medicines Development and Medical Affairs and Chief Medical Officer
Michael Parini, Executive Vice President and Chief Legal Officer
Alan Garber, Independent Director
Joshua Boger, Executive Director and Chairman of Science and Technology Committee
John Gray, Senior Vice President Genetic Therapies
Margaret McGlynn, Independent Director
Sangeeta Bhatia, Director
Terrence Kearney, Independent Director
Ian Smith, CFO, Executive Vice President
Paul Silva, Senior Vice President Corporate Controller
David Altshuler, Independent Director
Jeffrey Chodakewitz, Chief Medical Officer and Senior Vice President - Global Medicines Development
Elaine Ullian, Co-Lead Independent Director
Amit Sachdev, Senior Vice President - Global Government Strategy, Market Access and Value
David Greenway, Director
Charles Wagner, CFO, Executive Vice President
Bruce Sachs, Co-Lead Independent Director
Lloyd Carney, Independent Director
Michael Partridge, Vice President - Investor Relations
Yuchun Lee, Independent Director
Kimberly White, Senior Vice President and Chief Communications Officer
Stuart Arbuckle, Chief Commercial Officer and Executive VP
Thomas Graney, CFO, Senior Vice President
Charles Milstein, Executive Vice President Chief Legal and Administrative Officer
Jeffrey Leiden, Chairman of the Board and Presidentident, CEO

Stock Performance Indicators

Did you try this?

Run Financial Widgets Now

   

Financial Widgets

Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
All  Next Launch Module

Also Currentnly Active

Purchased few shares of
3 hours ago
Traded for 1243.01
Purchased over 40 shares of
3 hours ago
Traded for 65.56
Purchased over 20 shares of
3 hours ago
Traded for 141.57
Also please take a look at World Market Map. Please also try Cryptocurrency Arbitrage module to find pairs of digital assets on multiple exchanges that are traded at a risk free arbitrage.
Search macroaxis.com